Use of injectable GLP-1 weight-loss drugs skyrockets among teens

Initially, such drugs were approved solely to manage diabetes. After the FDA’s 2021 ruling for weight loss, however, their use skyrocketed. That was true especially among young people. Some GLP-1s are approved for kids as young as 12.

From 2020 to 2023, prescriptions for these injectables in adolescents and young adults jumped nearly six-fold — by 594 percent. That’s according to a June 2024 study in the Journal of the American Medical Association.

https://www.snexplores.org/article/teen-use-of-glp-1-weight-loss-drugs